A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy
2023 · BMC Medicine · 14 citations
https://doi.org/10.1186/s12916-023-03094-0